Paediatric rheumatology expert group meeting

• Date:
  fredag, 4 december 2009, Hela dagen
• Plats:
  European Medicines Agency, Amsterdam, the Netherlands

This meeting is aiming to discuss various aspects of the development, clinical use and pharmacovigilance of medicines for juvenile idiopathic arthritis and other paediatric rheumatic diseases.

Documents

Agenda - Paediatric rheumatology expert group meeting

Reference Number: EMA/809438/2009

Paediatric rheumatology expert group meeting - Conclusions

Reference Number: EMA/89878/2010

Biomarkers and clinical trials, Dr Patricia Woo

Design of paediatric rheumatology studies time to move to active comparator, Dr Nicolino Ruperto

Development of a Consolidated Pediatric Rheumatology Observational Registry, Dr Jeffrey Siegel

EMA guidelines, Dr Marion Haberkamp

Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focusing on Immune modulatory drugs, Dr Nico Wulffraat

Paediatric Pharmacovigilance, Dr Dirk Mentzer

Proposal for an international registry for juvenile idiopathic arthritis patients treated with methotrexate, Dr Nicolino Ruperto

Role of EMA in Patient Registries, Dr Jan Petracek

Review of answers from experts to EMA questions, Dr Richard Vesely

Overview of Paediatric Investigation Plans in Paediatric Rheumatology, Dr Richard Vesely, Dr Emma Sala Soriano